Cancer Medicine, ‎20457634

Journal

Publications

  1. 2016
  2. Published

    The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma

    Leila Khoja, Oct 2016, In: Cancer Medicine. 5, 10, p. 2792-2799 8 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2017
  4. Published
  5. 2018
  6. Published

    Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone

    1 Mar 2018, In: Cancer Medicine. 7, 3, p. 931-939

    Research output: Contribution to journalArticlepeer-review

  7. 2021
  8. Published

    Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy

    Paul Foster, Apr 2021, In: Cancer Medicine. 10, 8, p. 2812-2825 14 p.

    Research output: Contribution to journalArticlepeer-review

  9. E-pub ahead of print

    International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: a qualitative study

    Ameeta Retzer, Melanie Calvert, Khaled Ahmed, , , , , , , , , , , , , , & Derek Kyte, 5 Jul 2021, (E-pub ahead of print) In: Cancer Medicine.

    Research output: Contribution to journalArticlepeer-review